Validation of the Urgency Perception Scale
Authors:
- 10 February 2005
- journal article
- clinical trial
- Published by Wiley in BJU International
- Vol. 95 (4) , 591-596
Abstract
OBJECTIVE: To ascertain the validity and responsiveness of the Urgency Perception Scale (UPS) as an indicator of perceived urinary urgency. PATIENTS AND METHODS: The UPS was developed to assess perceived urinary urgency in clinical studies evaluating the efficacy of the antimuscarinic drug, tolterodine, for treating the overactive bladder (OAB) syndrome. Secondary analyses of clinical and patient assessment data from three clinical studies of tolterodine were conducted to evaluate the UPS. Construct validity was assessed by correlations between the UPS and patient voiding diary variables and other patient assessments, including: perception of bladder condition; perception of treatment benefit; the Medical Outcomes Study Short‐Form 36 health survey; the King's Health Questionnaire; the OAB Questionnaire; and the Overall Treatment Effect scale. RESULTS: The UPS correlated well with the patients’ perception of bladder condition (correlation coefficients − 0.29 to − 0.46; all P < 0.001) and with the voiding diary variables, especially incontinence episodes (−0.30 to − 0.41) and pad usage (−0.25 to − 0.38; all P < 0.001). An improvement in UPS score at the end of treatment was consistently reflected by significant improvements among all voiding variables. CONCLUSION: Urinary urgency is a central symptom of OAB and is particularly bothersome because of its unpredictability and consequent impact on daily life. The UPS is a valid scale by which urinary urgency can be assessed subjectively, and provides a useful tool for research into urinary urgency.Keywords
This publication has 14 references indexed in Scilit:
- Prevalence and burden of overactive bladder in the United StatesWorld Journal of Urology, 2003
- Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: The OAB-qQuality of Life Research, 2002
- A multicenter, prospective, open-label study of tolterodine extended-release 4 mg for overactive bladder: The speed of onset of therapeutic assessment trial (STAT)Clinical Therapeutics, 2002
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- Health-related quality of life of patients with overactive bladder receiving immediate-release tolterodineThe European Journal of Health Economics, 2001
- NONINVASIVE OUTCOME MEASURES OF URINARY INCONTINENCE AND LOWER URINARY TRACT SYMPTOMS: A MULTICENTER STUDY OF MICTURITION DIARY AND PAD TESTSJournal of Urology, 2000
- Recommendations for Evaluating the Validity of Quality of Life Claims for Labeling and PromotionValue in Health, 1999
- A new questionnaire to assess the quality of life of urinary incontinent womenBJOG: An International Journal of Obstetrics & Gynaecology, 1997
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Measurement of health statusControlled Clinical Trials, 1989